Raynaud's syndrome: current trends.
D000527:Alprostadil; D011464:Epoprostenol / Q000627:therapeutic use; D006801:Humans; D010951:Plasma Exchange; D011458:Prostaglandins E / Q000627:therapeutic use; D011928:Raynaud Disease / Q000150:complications / Q000628:therapy; D013197:Stanozolol / Q000627:therapeutic use; D013562:Sympathectomy; D014665:Vasodilator Agents / Q000627:therapeutic use
D011458:Prostaglandins E; D014665:Vasodilator Agents; D013197:Stanozolol; D011464:Epoprostenol; D000527:Alprostadil